SARS-CoV-2 Ag Rapid Test
Manufactured by BioMaxima SA, Poland - www.biomaxima.com
Device identification number
2035
CE Marking
✓Yes
HSC common list (RAT)
✓Yes
Format
Manual, Near POC / POC
Physical Support
Cassette
Target type
Antigen
Specimen
Nasopharyngeal swab
Lineages detected
B.1.1.529 (Omicron), B.1.1.7 (Alpha), B.1.351 (Beta), B.1.617.2 (Delta), P.1 (Gamma)
Commercial Status
Commercialised
Last Update
2022-08-24 09:08:01 CET
Comments
Following verification, BioMaxima's SARS-CoV-2 Ag Rapid Test antigen test effectively identifies variants: Alpha (B.1.1.7), Beta (B.1.351), Gamma (P1), Delta (B.1 .617.2) and Omicron (B.1.1.529) of the coronavirus.
Assay Type
Immuno-Antigen
Reader Required
No
Method
Immunochromatography
Measurement
Qualitative
Time
10 minutes
Subclass
Capture
LOD
160 AU
Calibration
Not evaluated
Analysis of cross reactivity
Evaluated
False positives
2 AU
False negatives
5 AU
Precision
Evaluated
Accuracy
97 %
Reproducibility
Evaluated
Robustness
Evaluated
Clinical Sensitivity
95 %
Clinical Specificity
99 %
Type of antigen
Nucleoprotein
The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements